FDA Considers Incorporating Patient Input In Generic Drug Assessments
US Agency Mulls Changes But Acknowledges Challenges For Off-Patent Medicines
The popular patient-focused drug development model for new drugs might not fit for generics, in part because the affected patient groups would be much larger.
